- Home
- RETO vs TENX Comparison
RETO vs TENX Comparison
Compare RETO & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RETO
- TENX
- Stock Information
- Founded
- RETO 1999
- TENX 1967
- Country
- RETO China
- TENX United States
- Employees
- RETO N/A
- TENX N/A
- Industry
- RETO Multi-Sector Companies
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- RETO Consumer Discretionary
- TENX Health Care
- Exchange
- RETO Nasdaq
- TENX Nasdaq
- Market Cap
- RETO 24.7M
- TENX 21.6M
- IPO Year
- RETO 2017
- TENX N/A
- Fundamental
- Price
- RETO $2.09
- TENX $5.95
- Analyst Decision
- RETO
- TENX Strong Buy
- Analyst Count
- RETO 0
- TENX 3
- Target Price
- RETO N/A
- TENX $16.00
- AVG Volume (30 Days)
- RETO 41.2K
- TENX 44.3K
- Earning Date
- RETO 07-07-2025
- TENX 08-12-2025
- Dividend Yield
- RETO N/A
- TENX N/A
- EPS Growth
- RETO N/A
- TENX N/A
- EPS
- RETO N/A
- TENX N/A
- Revenue
- RETO $1,828,976.00
- TENX N/A
- Revenue This Year
- RETO N/A
- TENX N/A
- Revenue Next Year
- RETO N/A
- TENX N/A
- P/E Ratio
- RETO N/A
- TENX N/A
- Revenue Growth
- RETO N/A
- TENX N/A
- 52 Week Low
- RETO $1.91
- TENX $2.80
- 52 Week High
- RETO $18.20
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- RETO 29.05
- TENX 51.83
- Support Level
- RETO $3.05
- TENX $5.62
- Resistance Level
- RETO $3.15
- TENX $6.35
- Average True Range (ATR)
- RETO 0.25
- TENX 0.46
- MACD
- RETO -0.07
- TENX 0.01
- Stochastic Oscillator
- RETO 31.45
- TENX 41.49
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.